Advanced in Mesenchymoma

Dr. Ying J. Hitchcock

Radiation Oncology
1950 Circle Of Hope Drive, 
Salt Lake City, UT 
Offers Telehealth
32 Years of Experience
Advanced in Mesenchymoma
1950 Circle Of Hope Drive, 
Salt Lake City, UT 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Ying Hitchcock is a Radiation Oncologist in Salt Lake City, Utah. Dr. Hitchcock has been practicing medicine for over 32 years and is rated as an Advanced provider by MediFind in the treatment of Mesenchymoma. Her top areas of expertise are Tongue Cancer, Adult Soft Tissue Sarcoma, Angiosarcoma of the Scalp, and Undifferentiated Pleomorphic Sarcoma.

Her clinical research consists of co-authoring 64 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Peking Union Medical College, 1994
Residency
Roswell Park Cancer Institute
Specialties
Radiation Oncology
Licenses
Radiology in UT
Board Certifications
American Board Of Radiology
Hospital Affiliations
Primary Children's Hospital
Languages Spoken
English
Mandarin
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
BridgeSpan
  • EPO
  • HMO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Deseret Mutual Benefit Administrators
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Regence
  • EPO
  • PPO
SelectHealth
  • HMO
  • POS
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
University of Utah Health
  • EPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

Huntsman Cancer Institute
1950 Circle Of Hope Drive, Salt Lake City, UT 84112
Other Locations
University of Utah Farmington Health Center
165 North University Avenue, Farmington, UT 84025

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Randomized Phase II Trial for Patients With p16 Positive, Non-Smoking Associated, Locoregionally Advanced Oropharyngeal Cancer
A Randomized Phase II Trial for Patients With p16 Positive, Non-Smoking Associated, Locoregionally Advanced Oropharyngeal Cancer
Enrollment Status: Completed
Publish Date: October 09, 2025
Intervention Type: Drug, Radiation
Study Drug: Cisplatin
Study Phase: Phase 2
A Randomized Phase II/III Trial of De-Intensified Radiation Therapy for Patients With Early-Stage, P16-Positive, Non-Smoking Associated Oropharyngeal Cancer
A Randomized Phase II/III Trial of De-Intensified Radiation Therapy for Patients With Early-Stage, P16-Positive, Non-Smoking Associated Oropharyngeal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: October 09, 2025
Intervention Type: Other, Procedure, Drug, Biological, Radiation
Study Drugs: Cisplatin, Nivolumab
Study Phase: Phase 2/Phase 3
Pazopanib Neoadjuvant Trial in Non-Rhabdomyosarcoma Soft Tissue Sarcomas (PAZNTIS): A Phase II/III Randomized Trial of Preoperative Chemoradiation or Preoperative Radiation Plus or Minus Pazopanib (NSC# 737754)
Pazopanib Neoadjuvant Trial in Non-Rhabdomyosarcoma Soft Tissue Sarcomas (PAZNTIS): A Phase II/III Randomized Trial of Preoperative Chemoradiation or Preoperative Radiation Plus or Minus Pazopanib (NSC# 737754)
Enrollment Status: Active_not_recruiting
Publish Date: August 11, 2025
Intervention Type: Drug, Radiation, Procedure
Study Drugs: Doxorubicin, Ifosfamide, Pazopanib
Study Phase: Phase 2/Phase 3
A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer
A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 20, 2025
Intervention Type: Biological, Radiation
Study Drug: Cetuximab
Study Phase: Phase 3
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 17, 2024
Intervention Type: Radiation
Study Phase: Phase 2/Phase 3
A Phase I and Expansion Cohort Study of Adjuvant Cisplatin, Intensity-Modulated Radiotherapy, and MK-3475 (Pembrolizumab) in High-Risk Head and Neck Squamous Cell Carcinoma (HNSCC)
A Phase I and Expansion Cohort Study of Adjuvant Cisplatin, Intensity-Modulated Radiotherapy, and MK-3475 (Pembrolizumab) in High-Risk Head and Neck Squamous Cell Carcinoma (HNSCC)
Enrollment Status: Completed
Publish Date: June 10, 2022
Intervention Type: Drug, Other, Radiation, Biological
Study Drugs: Cisplatin, Pembrolizumab
Study Phase: Phase 1
View 5 Less Clinical Trials

64 Total Publications

Target volume delineation of the neck for radiotherapy in nasopharyngeal carcinoma: CSTRO, CACA, CSCO, HNCIG, ESTRO, and ASTRO guidelines and contouring atlas.
Target volume delineation of the neck for radiotherapy in nasopharyngeal carcinoma: CSTRO, CACA, CSCO, HNCIG, ESTRO, and ASTRO guidelines and contouring atlas.
Journal: The Lancet. Oncology
Published: April 29, 2025
Similar Doctors
Advanced in Mesenchymoma
Dr. Jonathan D. Grant
Radiation Oncology
Advanced in Mesenchymoma
Dr. Jonathan D. Grant
Radiation Oncology

Ihc Health Services Inc

325 8th Ave, 
Salt Lake City, UT 
 (2.3 miles away)
801-408-3617
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jonathan Grant is a Radiation Oncologist in Salt Lake City, Utah. Dr. Grant is rated as an Advanced provider by MediFind in the treatment of Mesenchymoma. His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, Squamous Cell Lung Carcinoma, ALK-Positive Non-Small Cell Lung Cancer, and Thrombectomy. Dr. Grant is currently accepting new patients.

Experienced in Mesenchymoma
Dr. George M. Cannon
Radiation Oncology
Experienced in Mesenchymoma
Dr. George M. Cannon
Radiation Oncology

Ihc Health Services Inc

8 Th Ave C St, 
Salt Lake City, UT 
 (2.3 miles away)
801-408-1146
Languages Spoken:
English
See accepted insurances
Accepting New Patients

George Cannon is a Radiation Oncologist in Salt Lake City, Utah. Dr. Cannon is rated as a Distinguished provider by MediFind in the treatment of Mesenchymoma. His top areas of expertise are Anal Cancer, Adenoid Cystic Carcinoma, Lung Cancer, and Bone Tumor. Dr. Cannon is currently accepting new patients.

Experienced in Mesenchymoma
Dr. Matthew M. Poppe
Radiation Oncology
Experienced in Mesenchymoma
Dr. Matthew M. Poppe
Radiation Oncology

Huntsman Cancer Hospital

1950 Circle Of Hope Drive, Oncology, Suite 6700, 
Salt Lake City, UT 
 (0.1 miles away)
801-581-2396
Experience:
28+ years
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Matthew Poppe is a Radiation Oncologist in Salt Lake City, Utah. Dr. Poppe has been practicing medicine for over 28 years and is rated as an Advanced provider by MediFind in the treatment of Mesenchymoma. His top areas of expertise are Breast Cancer, Endometrial Cancer, Intraductal Papilloma, and Bone Tumor. Dr. Poppe is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Hitchcock's expertise for a condition
ConditionClose
    View All 7 Distinguished Conditions
    View All 23 Advanced Conditions
    View All 23 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile